This compound is a chemical reference standard used for the identification and quantification of an impurity in anastrozole. It is structurally characterized by a central benzene ring with cyanoalkyl and triazole substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1215780-15-6
Anastrozole
pharmaceutical raw material
2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxaldehyde
pharmaceutical intermediate
3,4-didehydronaratriptan
pharmaceutical intermediate
1-(Piperidin-4-yl)piperazine--hydrogen chloride (1/3)
pharmaceutical intermediate
N3-L-Val-OH (CHA)
pharmaceutical intermediate
4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile
pharmaceutical intermediate
4-(1H-1,2,4-Triazol-1-ylmethyl)aniline
pharmaceutical intermediate
2-[3-(1-cyanoethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
LXXANTDQIIXQBZ-UHFFFAOYSA-N
CC(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N